+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurostimulation Device Market by Product Type, Material Type, Power Source, Age Group, Technology, Application, End User - Global Forecast to 2030- Product Image
Neurostimulation Device Market by Product Type, Material Type, Power Source, Age Group, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Neurostimulation Device Market by Product Type, Material Type, Power Source, Age Group, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968618
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurostimulation Device Market grew from USD 6.62 billion in 2024 to USD 7.39 billion in 2025. It is expected to continue growing at a CAGR of 11.89%, reaching USD 13.00 billion by 2030.

Navigating the New Era of Neurostimulation Devices

The field of neurostimulation devices has matured from experimental therapies to a cornerstone of modern clinical practice, offering new hope for patients suffering from neurological, sensory, and chronic conditions. As devices become more sophisticated and indications expand, stakeholders across research, manufacturing, and healthcare delivery are poised to capitalize on the convergence of engineering breakthroughs, clinical evidence, and shifting regulatory landscapes.

This executive summary illuminates critical developments shaping the global neurostimulation market, providing readers with an accessible yet authoritative overview of key drivers, obstacles, and opportunities. By synthesizing the latest trends in technology, policy, and patient demand, this analysis equips decision-makers with the insights needed to navigate an increasingly complex and fast-evolving environment.

Breakthrough Innovations Redefining Industry Standards

Rapid advances in implantable electronics, miniaturization techniques, and biomaterials have accelerated the pace of innovation throughout the neurostimulation sector. Breakthroughs such as closed-loop deep brain stimulators capable of real-time neurofeedback are redefining treatment paradigms for movement disorders. Concurrently, minimally invasive approaches for spinal and sacral nerve stimulation are improving safety profiles and expanding the pool of eligible patients.

Beyond technical innovation, regulatory frameworks have undergone transformative shifts, with expedited approval pathways emerging in key jurisdictions to address unmet medical needs. Payer policies are adapting to demonstrate real-world value, aligning reimbursement with evidence of sustained clinical benefit. Meanwhile, patient advocacy groups have gained influence, driving demand for personalized therapies and patient-centric outcome measures. Together, these forces are reshaping market dynamics and accelerating the adoption of next-generation neurostimulation solutions.

Tariff Dynamics Shaping US Market Access

The introduction of new tariff schedules in the United States, effective in 2025, has injected additional complexity into the supply chains for neurostimulation components. Import duties on critical semiconductors and precision metals have increased manufacturing costs, compelling original equipment manufacturers to reevaluate sourcing strategies and consider nearshoring options. This shift has spurred investment in domestic production capabilities for key materials, aiming to reduce exposure to volatile international trade policies.

At the same time, higher tariffs have driven up the landed cost of finished devices, prompting end users to negotiate more stringent pricing terms. Hospitals and specialty clinics are exploring group purchasing agreements and alternative procurement models to manage budgetary constraints. Importantly, these cost pressures have also galvanized a push for design efficiency, with companies seeking to optimize power consumption, reduce component counts, and streamline assembly processes. As a result, the tariff landscape is influencing not only distribution economics but also the trajectory of device innovation and manufacturing excellence.

Segment-Specific Demands Driving Tailored Solutions

Based on product type, the market is studied across Cochlear Implants, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), and Vagus Nerve Stimulators (VNS), revealing diverse growth trajectories. Cochlear implants continue to lead adoption due to an aging population and rising prevalence of hearing loss, while DBS systems are gaining traction in movement disorder management thanks to refined targeting algorithms and adaptive stimulation capabilities.

Based on material type, market analysis distinguishes between Metallic Biomaterials and Polymeric Biomaterials. Metallic biomaterials dominate in load-bearing applications where durability is paramount, yet the emergence of advanced polymers offers improved biocompatibility and reduced imaging artifacts, broadening potential for long-term implants.

Based on power source, the landscape includes Non-Rechargeable Neurostimulators and Rechargeable Neurostimulators. While non-rechargeable devices retain a cost advantage for short-term therapies, rechargeables are increasingly preferred in chronic applications for their longevity, lower lifetime costs, and convenience for patients.

Based on age group, segmentation considers Adult, Geriatric, and Pediatric populations. Adult patients represent the largest segment by volume, but geriatric subgroups are experiencing the fastest growth as life expectancy rises and incidence of neurodegenerative conditions climbs. Pediatric usage remains specialized yet critical for congenital and early-onset disorders.

Based on technology, the market is divided into Implantable Neurostimulation Devices and Non-Implantable Devices. Implantable systems maintain the lead in serious chronic conditions, but external devices for pain management and rehabilitation are gaining momentum due to noninvasive profiles and ease of adjustment.

Based on application, the market encompasses Gastrointestinal Disorders, Hearing Loss, Neurological Disorders-including Dystonia, Epilepsy, Essential Tremor, and Parkinson’s Disease-Pain Management subdivided into Cancer Pain and Chronic Pain, Sleep Apnea, and Urinary & Fecal Incontinence covering Bowel Disorders and Overactive Bladder. Neurological disorder segments benefit from expanding clinical evidence and personalized programming, while pain management solutions are diversifying to address varying etiologies.

Based on end user, the analysis spans Ambulatory Surgery Centers (ASCs), Home Healthcare, Hospitals, and Specialty Clinics. Hospitals account for the majority of procedural volumes due to integrated care pathways, yet home healthcare models are on the rise driven by remote monitoring capabilities and patient preference for in-home therapies.

Regional Market Variances Inform Strategic Priorities

In the Americas region, strong reimbursement frameworks and a high prevalence of chronic conditions are fueling sustained demand for neurostimulation therapies. Leading private and public payers are investing in value-based contracting to align payment with long-term outcomes. Nonetheless, cost containment initiatives at the federal and state levels are intensifying price negotiations, encouraging manufacturers to demonstrate robust cost-effectiveness data.

Across Europe, Middle East & Africa, market drivers vary widely. Western European markets boast established clinical pathways and higher device penetration rates, while emerging economies are characterized by funding constraints and limited infrastructure. The rise of pan-regional procurement bodies and cross-border collaborations is helping to streamline access, yet regulatory heterogeneity continues to pose challenges for product registration and market launch.

In Asia-Pacific, rapid economic growth and expanding healthcare infrastructure are creating vast opportunities. Countries such as Japan, South Korea, and China are investing heavily in medical technology innovation, supported by government incentives and public-private partnerships. However, local competition and stringent local content requirements necessitate strategic alliances with regional manufacturers to navigate market entry effectively.

Competitive Dynamics Spotlight Innovators and Market Leaders

Market leadership is highly concentrated among a handful of global players renowned for technological expertise and extensive clinical networks. These industry titans continue to expand their portfolios through targeted acquisitions, in-licensing agreements, and platform extensions. Simultaneously, agile mid-sized firms are making strides with niche devices optimized for specific indications, leveraging rapid development cycles and specialized distribution channels.

Innovation partnerships between medtech companies and academic research centers have accelerated the translation of novel stimulation waveforms and neuroimaging-guided targeting into commercial products. Strategic alliances with software and data analytics firms are also on the rise, aimed at integrating artificial intelligence for predictive programming and remote patient management. New entrants face high barriers to entry, including regulatory scrutiny and reimbursement validation, but differentiated technology and compelling clinical data can quickly elevate emerging players to prominence.

Strategic Imperatives for Driving Growth and Innovation

First, companies should prioritize modular design approaches that facilitate rapid upgrades and minimize obsolescence, ensuring that long-term service contracts remain profitable. Next, strategic investment in domestic manufacturing capabilities can mitigate tariff exposure and strengthen supply chain resilience, particularly for high-value components. Additionally, forging collaborative research partnerships with centers of excellence will accelerate clinical validation and deepen market penetration in key therapeutic areas.

Leaders should also embrace digital health integration, coupling neurostimulation platforms with remote monitoring, telehealth consults, and data-driven care pathways to enhance patient adherence and capture real-world outcomes. Equally important is proactive engagement with payers to establish value-based reimbursement models that reward sustained clinical efficacy. Finally, targeted market entry strategies-leveraging local distribution partners and tailored commercialization plans-will be essential for capturing growth in diverse regional markets.

Robust Methodology Underpinning In-Depth Analysis

This analysis is founded on a comprehensive blend of primary and secondary research. Primary insights were gathered through interviews with leading neurosurgeons, pain specialists, biomedical engineers, and payers to validate market drivers, barriers, and emerging trends. Secondary research encompassed peer-reviewed journals, regulatory filings, industry white papers, and company annual reports to establish a robust data foundation.

Quantitative data was triangulated through rigorous validation techniques, ensuring consistency across multiple sources. Regional market assessments leveraged both top-down and bottom-up approaches to capture nuanced variations. All findings underwent peer review by a panel of subject matter experts to ensure accuracy, relevance, and impartiality.

Synthesizing Insights for the Future of Neurostimulation

The neurostimulation device landscape is evolving at an unprecedented pace, driven by synergistic advances in engineering, clinical practice, and regulatory policy. Key innovations in adaptive stimulation and biocompatible materials are unlocking new therapeutic frontiers, while payers and providers recalibrate value frameworks to support sustainable adoption.

Leaders who integrate strategic sourcing resilience, cutting-edge R&D partnerships, and digital health solutions will be best positioned to capture growth. Regional market variations underscore the necessity of flexible commercialization models that address diverse reimbursement environments and healthcare infrastructures. By synthesizing these insights, stakeholders can chart a path toward delivering transformative therapies that improve patient outcomes and drive long-term commercial success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cochlear Implants
    • Deep Brain Stimulators (DBS)
    • Sacral Nerve Stimulators (SNS)
    • Spinal Cord Stimulators (SCS)
    • Vagus Nerve Stimulators (VNS)
  • Material Type
    • Metallic Biomaterials
    • Polymeric Biomaterials
  • Power Source
    • Non-Rechargeable Neurostimulators
    • Rechargeable Neurostimulators
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
  • Technology
    • Implantable Neurostimulation Devices
    • Non-Implantable Devices
  • Application
    • Gastrointestinal Disorders
    • Hearing Loss
    • Neurological Disorders
      • Dystonia
      • Epilepsy
      • Essential Tremor
      • Parkinson’s Disease
    • Pain Management
      • Cancer Pain
      • Chronic Pain
    • Sleep Apnea
    • Urinary & Fecal Incontinence
      • Bowel Disorders
      • Overactive Bladder
  • End User
    • Ambulatory Surgery Centers (ASCs)
    • Home Healthcare
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Bayer AG
  • Beijing PINS Medical Co.
  • Bioventus Inc.
  • Boston Scientific Corporation
  • Cefaly Technology
  • Curonix LLC.
  • electroCore Inc
  • InCube Labs.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • Motif Neurotech, Inc.
  • Neurosigma, Inc.
  • Nevro Corporation
  • SceneRay Co., Ltd
  • Soterix Medical, Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of neurostimulation devices in pain management and treatment of chronic conditions
5.1.1.2. Advancements in neurostimulation technologies enabling enhanced patient outcomes
5.1.1.3. Increasing prevalence of neurological disorders coupled with the growing geriatric population
5.1.2. Restraints
5.1.2.1. High cost of neurostimulation devices and procedures hindering adoption in emerging economies
5.1.3. Opportunities
5.1.3.1. Rising investments in research and development to expand the scope of neurostimulation devices
5.1.3.2. Growing demand for minimally invasive neurostimulation therapies across diverse medical applications
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and long approval timelines for neurostimulation devices slowing market expansion
5.2. Market Segmentation Analysis
5.2.1. Product Type: Sacral nerve stimulators for improved bladder and bowel control
5.2.2. End User: Home healthcare enabling long-term management of neurological conditions
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Neurostimulation Device Market, by Product Type
6.1. Introduction
6.2. Cochlear Implants
6.3. Deep Brain Stimulators (DBS)
6.4. Sacral Nerve Stimulators (SNS)
6.5. Spinal Cord Stimulators (SCS)
6.6. Vagus Nerve Stimulators (VNS)
7. Neurostimulation Device Market, by Material Type
7.1. Introduction
7.2. Metallic Biomaterials
7.3. Polymeric Biomaterials
8. Neurostimulation Device Market, by Power Source
8.1. Introduction
8.2. Non-Rechargeable Neurostimulators
8.3. Rechargeable Neurostimulators
9. Neurostimulation Device Market, by Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Neurostimulation Device Market, by Application
10.1. Introduction
10.2. Gastrointestinal Disorders
10.3. Hearing Loss
10.4. Neurological Disorders
10.4.1. Dystonia
10.4.2. Epilepsy
10.4.3. Essential Tremor
10.4.4. Parkinson’s Disease
10.5. Pain Management
10.5.1. Cancer Pain
10.5.2. Chronic Pain
10.6. Sleep Apnea
10.7. Urinary & Fecal Incontinence
10.7.1. Bowel Disorders
10.7.2. Overactive Bladder
11. Neurostimulation Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers (ASCs)
11.3. Home Healthcare
11.4. Hospitals
11.5. Specialty Clinics
12. Americas Neurostimulation Device Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Neurostimulation Device Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Neurostimulation Device Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. Nexalin's Gen-3 Halo headset trial explores therapeutic potential for veterans with brain injuries
15.3.2. ShiraTronics reveals groundbreaking results of implantable neurostimulation system for chronic migraine relief at ASPN Conference
15.3.3. FDA's approval of Medtronic's Percept RC neurostimulator revolutionizes personalized DBS therapy
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEUROSTIMULATION DEVICE MARKET MULTI-CURRENCY
FIGURE 2. NEUROSTIMULATION DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. NEUROSTIMULATION DEVICE MARKET RESEARCH PROCESS
FIGURE 4. NEUROSTIMULATION DEVICE MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEUROSTIMULATION DEVICE MARKET DYNAMICS
TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 77. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 80. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 81. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 82. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 90. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 124. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 128. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 129. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 132. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 133. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 137. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 138. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 151. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 154. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 155. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 156. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 206. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 209. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 210. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 232. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 237. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 238. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 241. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 243. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 246. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 250. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 251. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 254. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 255. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 256. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 260. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 263. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 264. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 265. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 268. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 269. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 273. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 274. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 286. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 287. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 290. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 291. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 292. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 313. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 314. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 315. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 317. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 318. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
TABLE 319. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 322. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
TABLE 323. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 324. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neurostimulation Device market report include:
  • Abbott Laboratories
  • Bayer AG
  • Beijing PINS Medical Co.
  • Bioventus Inc.
  • Boston Scientific Corporation
  • Cefaly Technology
  • Curonix LLC.
  • electroCore Inc
  • InCube Labs.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • Motif Neurotech, Inc.
  • Neurosigma, Inc.
  • Nevro Corporation
  • SceneRay Co., Ltd
  • Soterix Medical, Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 13 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2024-2032 - Product Image

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Neurostimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neurostimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Neurostimulation Devices Market 2024-2028 - Product Image

Neurostimulation Devices Market 2024-2028

  • Report
  • 182 Pages
  • Global
From
Neurostimulation Devices - Global Strategic Business Report - Product Image

Neurostimulation Devices - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Implantable Neurostimulation Devices Market Report 2025 - Product Image

Implantable Neurostimulation Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Neurostimulator Market

The Neurostimulator market is a subset of the Neurology Devices market, which includes a variety of medical devices used to diagnose and treat neurological conditions. Neurostimulators are devices that use electrical stimulation to treat neurological disorders, such as chronic pain, epilepsy, and Parkinson's disease. Neurostimulators are typically implanted in the body and can be used to stimulate the brain, spinal cord, or peripheral nerves. Neurostimulators can also be used to treat depression, anxiety, and other mental health conditions. Neurostimulators are typically used in combination with other treatments, such as medications, physical therapy, and lifestyle changes. The market for Neurostimulators is growing, as more people are turning to these devices to treat neurological conditions. Some companies in the Neurostimulator market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.